A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

While substantial progress has been made in sharing data from clinical trials, many top-selling medicines still fall short ...

The bidirectional research examines both laboratory findings and human clinical trial data, revealing that the medicinal use ...

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with ...

Eli Lilly said the treatment, a once-daily pill called muvalaplin, showed reductions in Lp (a) levels compared to placebo. Injectables are currently in Phase 3 development, but "these are the first ...

If – God forbid – I show the biomarkers associated with the probable development of Alzheimer’s, I will receive three doses ...

Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...

In response, DOL made clear that employees may take FMLA leave for the treatment of their own serious health condition, even ...

Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.